Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REMICRUSH: Remifentanil vs Neuromuscular Blockade for Rapid Sequence Intubation
NCT03960801Phase 3Completed
- Sponsor
- CHU de Nantes
- Start
- Oct 2019
- Primary completion
- Apr 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of remifentanil in tracheal intubation, sponsored by CHU de Nantes. Started Oct 2019; status: completed.
02
Drugs
remifentanil
03
Conditions
tracheal intubation
Beyond the preview
Go deeper on NCT03960801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03960801.